Loading...
Optimising plasma levels of clozapine during metabolic interactions: a review and case report with adjunct rifampicin treatment
BACKGROUND: Clozapine is the only licensed medication for treatment-resistant schizophrenia. The metabolism of clozapine is affected by multiple pharmacokinetic interactions, so the co-administration of adjunct medications can have a significant clinical effect. The anti- tuberculosis medication rif...
Saved in:
| Published in: | BMC Psychiatry |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4542109/ https://ncbi.nlm.nih.gov/pubmed/26265348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-015-0536-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|